Skip to main
CGIX
CGIX logo

Cancer Genetics (CGIX)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy Cancer Genetics (CGIX) Stock

About Cancer Genetics (CGIX)

Vyant Bio, Inc. is a biotechnology company, which engages in drug discovery for complex neurodevelopmental and neurodegenerative disorders. The firm's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning. Its programs are focused on identifying repurposed and novel small molecule clinical candidates for r...read more
Market cap$1.23M
Today's volume
Revenue (TTM)
Avg. daily volume18.28K
EBITDA (TTM)
Open
Price / earnings ratio-0.09x
Today's range
Debt / equity
52 week range$0.14 - $1.58
5 year debt / equity-15.01x
Beta (LTM)0.99x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsMar 31, 2021
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jul 09, 2025, the market cap for CGIX stock is $1.23M

The current P/E ratio for CGIX stock is -0.09

The 52-week high for CGIX stock is $1.58. The current CGIX stock price $undefined is 100.00% below its 52-week high

The 52-week low for CGIX stock is $0.14. The current CGIX stock price $undefined has increased 100.00% from its 52-week low

No, the CGIX stock does not pay dividends to its shareholders

How to buy CGIX stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in CGIX stock

    Navigate to the Explore page. Then, type CGIX into the search bar. When you see CGIX stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased CGIX stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

Cancer Genetics Stock Earnings

The value each CGIX share was expected to gain vs. the value that each CGIX share actually gained.

Cancer Genetics (CGIX) reported earnings per share (EPS) of $0, estimates of $0 by . In the same quarter last year, Cancer Genetics's earnings per share (EPS) was $0. Cancer Genetics is expected to release next earnings on 03/31/2021, with an earnings per share (EPS) estimate of $0.

Buy Cancer Genetics (CGIX) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.